A guide to fluoroscopic identification and design of bioprosthetic valves: A reference for valve‐in‐valve procedure
- 19 March 2012
- journal article
- valvular and-structural-heart-diseases
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 81 (5), 853-861
- https://doi.org/10.1002/ccd.24419
Abstract
Surgical aortic valve replacement remains the therapy of choice in majority of patients with aortic stenosis. Bioprosthetic heart valves are often preferred over mechanical valves as they preclude the need for anticoagulation with its associated risks of bleeding and thromboembolism. However, bioprosthetic heart valves undergo structural deterioration and eventually fail. Reoperation is the standard treatment for structural failure of the bioprosthetic valve, stenosis or regurgitation but can carry a significant risk, especially in elderly patients with multiple comorbidities. Transcatheter aortic valve implantation has recently been established as a feasible alternative to conventional valve surgery for the management of high-risk elderly patients with aortic stenosis. This treatment modality has also been shown to be of benefit in the management of degenerated aortic bioprosthesis as a valve-in-valve procedure. The success of this procedure depends on a good understanding of the failing bioprostheses. This not only includes the device design but its radiological/fluoroscopic appearance and how it correlates with the implanted valve, as transcatheter aortic valve implantation is performed under fluoroscopic guidance. Here we illustrate the fluoroscopic appearance of 11 commercially available surgical bioprostheses and two commercially available transcatheter heart valves and discuss important aspects in their design which can influence outcome of a valve-in-valve procedure. We have also collated relevant information on the aspects of the design of a bioprosthetic valve, which are relevant to the valve-in-valve procedure.Keywords
This publication has 19 references indexed in Scilit:
- Reoperation of Left Heart Valve Bioprostheses According to Age at ImplantationCirculation, 2011
- Transcatheter Aortic-Valve Implantation — At What Price?New England Journal of Medicine, 2011
- Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?Interactive CardioVascular and Thoracic Surgery, 2010
- Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related OutcomesCirculation, 2009
- Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National DatabaseThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Aortic Valve Replacement: Choice Between Mechanical Valves and BioprosthesesJournal of Cardiac Surgery, 2008
- Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving systemCatheterization and Cardiovascular Interventions, 2007
- Very Long-Term Survival Implications of Heart Valve Replacement With Tissue Versus Mechanical Prostheses in Adults <60 Years of AgeCirculation, 2007
- Treatment of Calcific Aortic Stenosis With the Percutaneous Heart ValveJournal of the American College of Cardiology, 2006
- Decrease in operative risk of reoperative valve surgeryThe Annals of Thoracic Surgery, 1993